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Table 1
Case-Control Analysis of CARD15 702Trp Allele Association with UC, Stratified by IBD5
Status
Patient Group
702Trp Allele
Frequency
(%)
P Value
(compared
to HC)a
Relative Risk
(95% CIs)a PARb
Healthy controls (232) 2.80
Ulcerative colitis, overall (278) 5.94 .016 2.14 (1.11–4.12) .03
IBD5 “nonrisk” homozygotes (75) 3.33 .737 NA NA
IBD5 heterozygotes (152) 6.25 .019 2.28 (1.11–4.70) .04
IBD5 “risk” homozygotes (51) 8.82 .004 3.40 (1.41–8.18) .06
a P value and RR were calculated using the Fisher’s Exact Test.
b PAR p population attributable risk.
Am. J. Hum. Genet. 73:1465–1466, 2003
Further Evidence of IBD5/CARD15 (NOD2) Epistasis
in the Susceptibility to Ulcerative Colitis
To the Editor:
We read with interest the two recent articles describing
analyses of the IBD5 (MIM 606348) risk haplotype and
inflammatory bowel disease (IBD) in European cohorts
(Giallourakis et al. 2003; Mirza et al. 2003). In both
European cohorts, the association with the IBD5 risk
haplotype and Crohn disease (CD [MIM 266600]) was
replicated. Mirza et al. (2003) additionally provided ev-
idence for interaction between IBD5 and CARD15
(NOD2) (MIM 605956) in CD, a finding not seen in
the subsequent paper by Giallourakis et al. (2003) or in
our own transmission/disequilibrium testing (TDT) an
alysis (Negoro et al. 2003). Subsequent genotype-phe-
notype analysis by Giallourakis et al. (2003) found no
association between IBD5 and clinical subgroups of pa-
tients with CD. In contrast, our group has recently pub-
lished a case-control study of U.K. whites demonstrating
that the association between IBD5 and CD was confined
to those individuals with perianal disease (Armuzzi et
al. 2003). It would be interesting to know whether as-
sociation with this particular phenotype was evaluated
in the Giallourakis cohort.
In 187 trios with ulcerative colitis (UC [MIM
191390]), Giallourakis et al. (2003) also reported a
novel association between the IBD5 risk haplotype and
UC. This association was most pronounced in those in-
dividuals possessing one of the three common CD-as-
sociated CARD15 variant alleles, suggesting an epistatic
relationship between these replicated CD loci in patients
with UC. In our British patients, we observed a similar
linkage disequilibrium (LD) pattern across this locus.
However, using both TDT (105 transmissions to 124
nontransmissions, ) and case-control studies, wePp .24
were unable to demonstrate association between the
IBD5 risk haplotype and UC (Armuzzi et al. 2003; Ne-
goro et al. 2003). However, stratification of the IBD5
results in UC by CARD15 status was not performed.
Following the report by Giallourakis et al. (2003), we
therefore stratified our trios to assess the transmissions
of IGR2060a_1 (an IBD5 risk haplotype–tagging SNP)
from heterozygous parents to affected offspring who
also carried at least one CARD15 risk allele, revealing
14 transmissions to 12 nontransmissions ( ). ThePp .78
lack of association may reflect a true relationship, or it
may be a type I error due to the relatively weak power
of this analysis. We therefore genotyped for the three
common CARD15 variants and IBD5 haplotype–tag-
ging SNP to assess any epistatic association in a more
powerful case-control study of 278 patients with UC
(largely independent of the UC trios) and 232 healthy
controls (HC). We found a novel association between
the CARD15 702Trp variant and UC (table 1). This
association was not significant in the IBD5 wild-type
homozygotes but became significant in the IBD5 het-
erozygotes and even more significant in the IBD5 “risk”
homozygotes, supporting the theory of an epistatic re-
lation between the IBD5 locus and CARD15 in the
susceptibility to UC (table 1). However, there was no
such relationship between UC and the 908Arg or
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Table 2
Transmissions versus Nontransmissions in Common CD-
Associated CARD15 Variants from the TDT of 244 UC Trios
Variant Transmissions Nontransmissions P Value
702Trp 24 16 .26
908Arg 3 12 .066
Leu1007fsinsC 8 15 .22
Leu1007fsinsC CARD15 alleles (908Arg: HC 0.65%,
UC 0.73%, ; Leu1007fsinsC: HC 2.14%, UCPp .73
0.74%, ), despite IBD5 stratification (data notPp .057
shown). We found no particular UC phenotype (need
for surgery, age at onset, disease distribution) associated
with the CARD15 702Trp allele, with or without IBD5
stratification.
We believe that these data confirm the presence of
an IBD5/CARD15 epistatic relationship in the suscep-
tibility to UC (although the overall population effect
is relatively small [table 1]), in contrast to the non-
epistatic relationship between IBD5/CARD15 and CD
seen in both our populations and that of Giallourakis
et al. (2003). Our data, however, suggest that this ep-
istatic effect is seen exclusively with the 702Trp variant,
supporting other data that imply that the 702Trp poly-
morphism may possess unique properties not shared
with the other CARD15 CD-associated variants (Bo-
nen et al. 2003; Rahman et al. 2003; Sugimura et al.
2003). Indeed, our data suggest a trend toward under-
transmission/reduced allele frequency of 908Arg/
Leu1007fsinsC in UC (table 2 and the paragraph above).
Further work is needed to determine whether the epi-
static IBD5/CARD15 interaction in UC is a “global”
CARD15 phenomenon or, as we have suggested, is re-
stricted to the 702Trp allele. These data support the
theory that UC and CD are related polygenic conditions
that share some, but not all, susceptibility genes.
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